Xeris Pharmaceuticals, Inc.
Share on:
| Name: | Xeris Pharmaceuticals, Inc. |
| Jurisdiction: | Idaho |
| Legal type: | Foreign Business Corporation |
| Status: | Active-Good Standing |
| Date of registration: | 30 Sep 2024 (a year ago) |
| Financial Date End: | 30 Sep 2026 |
| Entity Number: | 5914876 |
| Place of Formation: | DELAWARE |
| File Number: | 957408 |
| Principal Address: | 1375 W. FULTON ST, SUITE 1300 CHICAGO, IL 60607 |
| Mailing Address: | SUITE 1300 1375 W FULTON STREET CHICAGO, IL 60607 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 10020 W FAIRVIEW AVE, STE 104, BOISE, ID 83704 |
| Name | Role | Address | Appointed On |
|---|---|---|---|
| Beth Hecht | Secretary | 1375 W FULTON STREET, CHICAGO, IL 60607 | 2025-08-12 |
| Filing Name | Filing Number | Filing date |
|---|---|---|
| Annual Report | 0006398779 | 2025-08-12 |
| Registered Agent Name/Address Change (mass change) | 0006279919 | 2025-05-27 |
| Initial Filing | 0005914876 | 2024-09-30 |
This company hasn't received any reviews.
Date of last update: 24 Aug 2025
Sources: Idaho Secretary of State